NCT07514065 2026-04-07
TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy
Tasly Pharmaceutical Group Co., Ltd
Phase 1 Recruiting
Clinical Trials
3 trialsInterventional × Metastatic Castration-Resistant Prostate Cancer Patients × Genitourinary × Clear all
NCT07135102 2025-08-24
A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection in Patients With Metastatic Castration-resistant Prostate Cancer
Shandong Cancer Hospital and Institute
Phase 1 Recruiting
NCT03643107 2025-01-23
Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)
Allarity Therapeutics
Phase 2 Completed